🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carolina Solis‐Herrera

The University of Texas at San Antonio Health Science Center

ORCID: 0000-0002-6215-9418
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy”.

Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy

Diabetologia(2020)10.1007/s00125-020-05254-w
N/A
1.1DataRank · unranked
33 citations

Carolina Solis‐Herrera, Angela Dardano, Andrea Mari, Andrea Tura, Laura Giusti +10 more

Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion

Diabetes Care(2020)10.2337/dc19-2177
N/A
0.943DataRank · unranked
29 citations

Giuseppe Daniele, Mariam Alatrach, Christina Agyin, Curtis Triplitt, John M. Adams +9 more

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf022
N/A
0.532DataRank · unranked
22 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl +94 more

Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin

Diabetes Care(2020)10.2337/dc19-1993
N/A
0.313DataRank · unranked
6 citations

John M. Adams, Carolina Solis‐Herrera, Curtis Triplitt, Ralph A. DeFronzo, Eugênio Cersósimo +1 more

Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects

Diabetes(2024)10.2337/db23-0457
N/A
0DataRank · unranked
4 citations

Devjit Tripathy, Robert Ćhilton, Andrea Hansis‐Diarte, Marzieh Salehi, Carolina Solis‐Herrera +3 more

Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects

Diabetes(2020)10.2337/db20-0039
N/A
0DataRank · unranked
35 citations

Devjit Tripathy, Xi Chen, Ivan Valdez, Muhammad Abdul‐Ghani, Carolina Solis‐Herrera +3 more

Repeated Withdrawal of a GLPR Agonist Induces Hyperleptinemia and Deteriorates Metabolic Health in Obese Aging UM‐HET3 Mice

Aging Cell(2025)10.1111/acel.70210
N/A
0DataRank · unranked
3 citations

Jiyuan Yin, Noah Lawrence, Jieyi Meng, Laurence T. Maeyens, Ziying Xu +9 more

Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes

Diabetes Obesity and Metabolism(2022)10.1111/dom.14885
N/A
0DataRank · unranked
28 citations

Marjorie Molina‐Wilkins, Geoffrey D. Clarke, Aurora Merovci, Carolina Solis‐Herrera, Eugênio Cersósimo +6 more

Leptin Reduction as a Required Component for Weight Loss

Diabetes(2023)10.2337/db23-0571
N/A
0DataRank · unranked
32 citations

Na Li, Wei Xiong, Guannan Li, Sijia He, Zhuzhen Zhang +13 more

Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes

The Journal of Clinical Endocrinology & Metabolism(2023)10.1210/clinem/dgad438
N/A
0DataRank · unranked
11 citations

Mariam Alatrach, Carolina Solis‐Herrera, Gozde Baskoy, John M. Adams, Andrea Hansis‐Diarte +5 more